HONG DO: Open Payments
NPI 1639683576 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,906 in 176 payments from 23 companies in 2025. Trend: 2023 $4,144 · 2024 $3,649 · 2025 $3,906
Food & beverage: $3,641Education: $265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $535 |
| Janssen Biotech, Inc. | 11 | $399 |
| Galderma Laboratories, L.P. | 13 | $392 |
| Regeneron Healthcare Solutions, Inc. | 15 | $359 |
| GENZYME CORPORATION | 16 | $272 |
| Amgen Inc. | 14 | $248 |
| UCB, Inc. | 14 | $221 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $218 |
| Organon LLC | 6 | $203 |
| PFIZER INC. | 6 | $179 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, RINVOQ, OTEZLA, Bimzelx, VTAMA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
